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Sphingosine-1-phosphate is a bioactive sphingolipid
that regulates proliferation, differentiation, migration,
and apoptosis. Sphingosine-1-phosphate is irreversibly
degraded by the highly conserved enzyme sphingosine-
1-phosphate lyase. Recent studies have suggested that
sphingosine-1-phosphate lyase expression affects ani-
mal development and cell fate decisions. Despite its cru-
cial role, mechanisms affecting expression of sphingo-
sine-1-phosphate lyase remain poorly understood. In
this study, regulation of sphingosine-1-phosphate lyase
gene expression was investigated in Caenorhabditis el-
egans, where lyase expression is spatially restricted to
cells of the developing and adult gut and is essential for
normal development. Deletion analysis and generation
of transgenic worms combined with fluorescence mi-
croscopy identified a 350-nucleotide sequence upstream
of the ATG start site necessary for maximal lyase expres-
sion in adult worms. Site-specific mutagenesis of a
GATA transcription factor-binding motif in the pro-
moter led to loss of reporter expression. Knockdown of
the gut-specific GATA transcription factor ELT-2 by
RNA interference similarly led to loss of reporter ex-
pression. ELT-2 interacted with the GATA factor-
binding motif in vitro and was also capable of driving
expression of a Caenorhabditis elegans lyase promoter-
-galactosidase reporter in a heterologous yeast system.
These studies demonstrate that ELT-2 regulates
sphingosine-1-phosphate lyase expression in vivo.
Additionally, we demonstrate that the human sphin-
gosine-1-phosphate lyase gene is regulated by a GATA
transcription factor. Overexpression of GATA-4 led to
both an increase in activity of a reporter gene as well
as an increase in endogenous sphingosine-1-phosphate
lyase protein.
Sphingosine 1-phosphate (S1P)1 is a sphingolipid signaling
molecule that regulates cell proliferation, migration, and apo-
ptosis and has been shown to play a role in mediating complex
physiological processes, including vascular maturation, im-
mune cell responses, and lymphocyte trafficking (1–7). S1P
mediates many of its effects through activation of a subgroup of
the Edg family of G protein-coupled receptors (8). Other effects,
especially those related to cell survival, appear to be mediated
through both receptor-dependent and receptor-independent
mechanisms (9). Intracellular S1P levels are determined by the
balance between its synthesis by phosphorylation of sphingo-
sine, catalyzed by sphingosine kinase, and its recycling back to
sphingosine catalyzed primarily by S1P phosphatase or its
irreversible degradation to ethanolamine phosphate and hexa-
decenal, catalyzed by sphingosine-1-phosphate lyase (SPL)
(10). Altered expression of each of the three major enzymes
controlling S1P metabolism has been shown to affect mamma-
lian cell fate decisions and survival (11–16). Understanding the
physiological mechanisms by which the expression and activity
of these enzymes are regulated may be useful in further eluci-
dating the role of S1P in physiology and disease and in provid-
ing novel approaches to manipulate S1P signaling for thera-
peutic purposes (17, 18).
SPL is a pyridoxal 5-phosphate-dependent enzyme that lo-
calizes to the endoplasmic reticulum (11, 19). Until recently,
SPL was presumed to be constitutively active and to serve a
housekeeping function in the cell. However, it has become clear
that SPL expression is influenced by a variety of factors. For
example, although SPL expression has been found in most
mammalian tissues with the exception of blood platelets, the
degree of expression demonstrated in mouse and human tis-
sues is quite variable, with the highest levels in liver, kidney,
and intestine and lesser amounts in muscle and brain (20, 21).
SPL expression in mouse embryonal carcinoma cells is up-
regulated during differentiation (22). In addition, SPL expres-
sion in the ecdysozoan protostomes Drosophila melanogaster
and Caenorhabditis elegans is developmentally regulated, re-
stricted to the gut, and required for normal development (23,
24). Despite this evidence of regulated SPL gene expression, no
mechanism for transcriptional regulation has yet been defined
nor have specific transcription factors involved in SPL expres-
sion been identified.
GATA transcription factors are a family of structurally
related DNA-binding proteins first identified as key regula-
tors of mammalian erythropoiesis (25). Members of this fam-
ily have been shown to regulate gene expression in a wide
variety of tissues, and functional homologs have been iden-
tified in fungi, Drosophila, and C. elegans. Vertebrate GATA
transcription factors have been subdivided into two func-
tional groups, GATA-1, -2, and -3, which are expressed in
hematopoietic stem cells and neurons and regulate thymo-
cyte, erythroid, megakaryocyte, and neuronal differentiation,
and GATA-4, -5, and -6, which are expressed in tissues of
mesodermal and endodermal origin and are involved in lung,
liver, cardiac, intestinal, and gonadal development and
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function (26). GATA transcription factors contain either
one or two structural domains with the zinc finger motif
CXNCX17CNXC, which confers the ability to bind specifically
to the consensus site (A/T)GATA(A/G). GATA transcription
factors appear capable of serving both repressor and en-
hancer functions and have been shown to repress, activate,
and/or spatially restrict the expression of various genes. Mul-
tiple GATA transcription factors have been identified in C.
elegans, where they affect genes involved in cell migration,
fusion, and cell fate specification in gut, hypodermis, vulva,
and nervous tissue development (27–32).
Here we have explored mechanisms of SPL gene regulation
in C. elegans, where a relatively small intergenic DNA se-
quence appears sufficient to promote maximal expression of a
GFP reporter construct in intestinal cells of the developing and
adult gut. A combination of deletion analysis and site-directed
mutagenesis defines a 350-bp regulatory region containing a
GATA transcription factor-binding site that is required for
normal SPL expression. We show that the C. elegans GATA
factor ELT-2 binds specifically to this site in vitro, is required
for expression of SPL in the gut, and is capable of enhancing
expression of the SPL promoter::-galactosidase fusion con-
struct in a heterologous yeast system. These results provide
novel insights into the cellular mechanisms that control S1P
metabolism and coordinate it with the complex developmental
cascades organizing embryogenesis. We also show that GATA
factors regulate SPL expression in human cells, indicating that
this and potentially other mechanism(s) governing the expres-
sion of genes of sphingolipid metabolism may be conserved
throughout evolution.
EXPERIMENTAL PROCEDURES
Generation and Expression of Reporter Gene Constructs for SPL
Deletional Analysis—An intergenic region of 512 nucleotides of up-
stream untranslated sequences corresponding to a position 3 to 515
relative to the SPL ATG start codon was utilized as the full-length
promoter region, as described previously (24). Deletional analysis of
this promoter was performed by generating constructs containing 350,
330, 300, 275, 250, 200, and 120 nucleotides upstream of the ATG start
codon. These were generated by PCR from the full-length promoter
template DNA using Vent DNA polymerase (New England Biolabs,
Beverly, MA), the upstream primers 5-120Y66, 5-200Y66, 5-250Y66,
5-275Y66, 5-300Y66, 5-330Y66, and 5-350Y66 and the downstream
primer 3-SmaIY66H1B (Table I). Following restriction enzyme diges-
tion, these PCR products were cloned into PstI and SmaI sites of the
GFP reporter plasmid pPD95.75 (gift of Andrew Fire). The resulting
constructs were subjected to DNA sequence analysis and used to gen-
erate transgenic C. elegans lines as described below.
Creation of Transgenic Animals—Worms were grown under stand-
ard conditions in nematode growth medium (33). Generation of dpy-
20(e1362) worms containing transgenic arrays was performed by mi-
croinjection of reporter construct DNA into the distal arm of the
hermaphrodite gonad, as described previously (34, 35). Reporter con-
struct DNA was co-injected with plasmid pMH86, allowing the recog-
nition of transformants by rescue of the Dpy phenotype (36). Expression
of the reporter was examined in both the rescued dpy-20 and rol-
6(su1006) backgrounds and found to be similar in both pattern and
intensity. In the case of the 350-nucleotide reporter, reporter DNA was
co-injected with the plasmid pRF4, which contains rol6(su1006), and
transformants were identified by the dominant roller phenotype (37).
Two independently derived stable lines for each construct were ana-
lyzed. GFP was visualized by mounting live transgenic nematodes on
5% agarose, 0.2% tricaine, 0.02% tetramisole in M9 and viewed by
fluorescence microscopy (Zeiss Axioskop) using a Chroma High Q GFP
long pass filter set (450 nm excitation and 505 nm emission).
Fluorescence Intensity Measurements and Imaging—Fluorescence
and Nomarski images were captured using a CCD digital camera
(Hamamatsu ORCA-ER) on a Zeiss Axioskop compound microscope.
Mean fluorescence intensity of GFP was determined for a 200  250
pixel box surrounding either the int1DL/VL or int1DR/VR cell pair in
the anterior gut and a 200  200 pixel box surrounding the int9L/R cell
pair in the posterior gut using the Openlab software package (version
3.1.5, Improvision). Autofluorescence was determined using wild type
(N2) hermaphrodites lacking transgene expression and subtracted from
measurements obtained from transgenic hermaphrodites. All worms
measured were in the mid-L4 stage of development to control for size of
the expressing cells. More than 20 animals having GFP expression in
both members of measured cell pair were examined for each transgene.
Statistical analysis was performed using InStat software (version 3.0b,
GraphPad Software Inc.). Two-tailed p values were calculated using a
Mann-Whitney test.
RNA Interference by Injection—A DNA fragment containing the full-
length elt-2 open reading frame and T7 promoter sequences at 5 and 3
ends was generated by PCR from the pJM68 plasmid template (a
full-length elt-2 clone in pBluescriptSK(), gift of James McGhee) using
Vent DNA polymerase and the primer pair 5-T7-ELT2 and 3-T7-ELT2
(Table I). Double-stranded RNA (dsRNA) was synthesized using the
MEGAscript RNAi in vitro transcription kit (Ambion, Inc., Austin, TX).
The dsRNA was injected as described (35) into the distal gonads of adult
C. elegans hermaphrodites of stable lines that express the 350-nucleo-
tide SPL reporter construct. Eight hours after injection, each hermaph-
TABLE I
Primers used in these experiments
Name Sequence
5-120Y66 5-TTTCTGCAGACTTTGTTTTTGAAGGGTAT-3
5-200Y66 5-CGACTGCAGTCAATTGAAAAGGAGTG-3
5-250Y66 5-TTTCTGCAGTGAAGTTGGTTTCATTTCC-3
5-275Y66 5-CCGCTGCAGTGTTTCTGAAAAAAGTT-3
5-300Y66 5-CGTCTGCAGTTCTTATCAGTATACTT-3
5-330Y66 5-GTTCTGCAGCGATTTTTGTGATAATG-3
5-350Y66 5-ATTCTGCAGATCCATGATTTTTCGTTTCT-3
3-SmaIY66H1B.4 5-CGAATCCCGGGTAACCTGAAAA-3
5-Y66GATAMut 5-TCGATTTTTGCGATCCTGACCACGTATCATATTC-3
3-Y66GATAMut 5-GAATATGATACGTGGTCAGGATCGCAAAAATCGA-3
5-ELT2-Start 5-TCTAGAACTAGTCCCGGGAGATCTATGGATAATAACTACAATGATAATG-3
5-Met-WT 5-GATCTGTCAATAACTGATAAAATCAGAAA-3
3-Met-WT 5-GATCTTTCTGATTTTATCAGTTATTGACA-3
5-Met-Mut 5-GATCTGTCAATAACGGATCCAATCAGAAA-3
3-Met-Mut 5-GATCTTTCTGATTGGATCCGTTATTGACA-3
5-T7-ELT2 5-TAATACGACTCACTATAGGAATGGATAATAACTACAATG-3
3-T7-ELT2 5-TAATACGACTCACTATAGGAGAATCTCCGTCGACCGCTTC-3
5-TripleGATA 5-TCGAGTTTGTGATAATGACCATTTGTGATAATGACCATTTGTGATAATGACCAG-3
3-TripleGATA-Xho 5-TCGACTGGTCATTATCACAAATGGTCATTATCACAAATGGTCATTATCACAAAC-3
5-SPL-WT 5-GATCCGTTTCTTTTCGATTTTTGTGATAATGACCACGTATCATATTC-3
3-SPL-WT 5-GATCGAATATGATACGTGGTCATTATCACAAAAATCGAAAAGAAACG-3
5-SPL-Mut 5-GATCCGTTTCTTTTCGATTTTTGCGATCCTGACCACGTATCATATTC-3
3-SPL-Mut 5-GATCGAATATGATACGTGGTCAGGATCGCAAAAATCGAAAAGAAACG-3
5-ELT-7 5-GATATCCTCGAGGAATTCATGCTCCCTGAAACTACTACTCTTCAACCA-3
3-ELT7 5-GATATCGAATTCCTCGAGCTATTCTTTTTTTGCTTGACGCCGCTTTCG-3
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rodite was transferred to a fresh culture plate, and 12-h cohorts of F1
progeny were established. Broods were assessed for L1 arrest and the
“gut-obstructed” phenotype as an indicator of effective knockdown of
ELT-2 expression. Broods with greater than 90% arrest in L1 were
examined daily with a dissecting microscope and by Nomarski micros-
copy (Zeiss Axioscop) (38). Control RNAi experiments were carried out
simultaneously employing dsRNA corresponding to the acn-1 (C42D8.5)
gene generated as described (39) from bacterial clones derived from a C.
elegans RNAi feeding library (40, 41). Broods were assessed for L1
arrest and evaluated for SPL reporter expression as described above.
Mutational Analysis of the SPL TGATAA Element—Site-directed
mutagenesis of the TGATAA motif located at 320 to 315 in the SPL
promoter was performed using the Stratagene Quikchange kit (La
Jolla, CA) and the primer pair 5-Y66GATAMut and 3-Y66GATAMut
(Table I), according to the manufacturer’s instructions. The resulting
PCR fragment containing the sequence change from TGATAA to
CGATCC was cloned into the PstI and SmaI sites of pPD95.75, and the
mutation was confirmed by nucleotide sequencing.
Electrophoretic Mobility Shift Assay (EMSA)—An ELT-2-GST fusion
protein was constructed by digesting pJM68 (28) with SmaI and XhoI,
isolating the ELT-2 fragment and ligating it into the SmaI/XhoI-di-
gested vector pGEX-4T, which places ELT-2 in-frame with GST. This
construct was expressed in Escherichia coli, and cells were harvested
after induction with isopropyl 1-thio--D-galactopyranoside, washed
with PBS, and sonicated three times with 20-s intervals. Triton X-100
was added to 1% final concentration, gently mixed in with the cells for
30 min, at which time 0.5 ml of glutathione-agarose (Sigma) was added
and incubated for another 30 min. After washing with PBS containing
1% Triton X-100, bound proteins were eluted with 10 mM reduced
glutathione in 50 mM Tris, pH 8. The eluted proteins were used for
EMSA with a 47-nucleotide DNA probe containing the wild type
TGATAA motif. The probe was labeled with polynucleotide kinase and
[-32P]ATP, followed by purification on a G-50 Sepharose column. DNA/
protein binding was performed using ELT-2-GST or purified ELT-2
protein (gift of James McGhee) in 25 mM HEPES, 50 mM KCl, 1 mM
dithiothreitol, 10 M zinc sulfate, 1 g of poly(dI/dC), 10% glycerol,
followed by electrophoresis on a 5% nondenaturing acrylamide gel. To
determine the specificity of the interaction between ELT-2 and the SPL
promoter, competition assays were performed using unlabeled oligonu-
cleotides corresponding to DNA elements of C. elegans SPL and metal-
lothionein (MT) promoters (42). These oligonucleotides contained either
a wild type or mutated GATA-binding site that ELT-2 was previously
shown to bind, in the case of the MT probe (Table I). Similarly, EMSA
was performed employing an ELT-7-GST fusion construct (ELT-7 cDNA
was kindly provided by Joel Rothman).
Transcriptional Activation of Reporters Using a Heterologous Yeast
System—SPL reporter plasmids were constructed by inserting double-
stranded oligonucleotides (complementary oligomers 5-tripleGATA
and 3-tripleGATA-Xho; Table I) containing three tandem repeats of the
conserved motif TGATAA and surrounding sequences from the C. el-
egans SPL promoter into the XhoI site of plasmid pLG178 (gift of Kyle
Cunningham) (43, 44). Clones containing inserts in forward and reverse
orientations were identified by PCR. In these constructs, lacZ expres-
sion is under the control of a minimal CYC1 promoter, and the SPL
promoter elements serve as upstream activating sequences. A construct
containing the elt-2 cDNA sequence in the YCpGAL vector allows
ELT-2 expression after galactose induction in yeast. A similar construct
containing the elt-2 cDNA sequence in antisense orientation serves as a
negative control. Co-transfection of elt-2 and SPL reporter constructs
was performed in yeast strain RE1006 (MATa can1-100 his3-11,15
leu2-3,112 trp1-1 ura3-52) using the lithium acetate method (45). Dou-
ble transformants were selected on synthetic complete medium contain-
ing glucose and lacking leucine and uracil (Leu Ura). Cells contain-
ing elt-2 and SPL reporter constructs were grown to log phase at 30 °C
in Leu Ura medium containing 2% raffinose as carbon source. To
induce transcription factor expression, galactose was added to a final
concentration of 2%, and cultures were incubated for an additional 6–8
h. Quantitative assays of -galactosidase activity were performed as
described previously (46). Similar studies were performed using a con-
struct driving expression of ELT-7.
Human SPL Luciferase Reporter Construction—A human BAC clone
containing the entire human SPL gene (RPCI11 432J9) was obtained
from CHORI BACPAC resources (bacpac.chori.org). A 13-kb fragment
from this BAC containing the SPL promoter region was cloned in plasmid
pBlueScript SKII(), and two different size fragments were generated by
restriction digestion with BamHI and KpnI, which were then cloned into
the plasmid pGL3-Basic (Promega). The resulting constructs, pGL3-
BamHI and pGL3-KpnI, harbor 7708 and 1825 bps, respectively, of se-
quences upstream of the ATG start codon of the SPL gene driving the
expression of a firefly luciferase reporter. SPL gene expression was ex-
amined by co-transfection of reporter constructs along with a plasmid
expressing human GATA-4. A control plasmid, pRL-CMV (Promega),
which provides constitutive expression of the sea pansy luciferase, was
utilized for normalizing the differences in transfection efficiency. Human
GATA-4 plasmid was a gift of Xiang-Xi Xu, Fox Chase Cancer Center,
Philadelphia (47). Transfections were performed using Lipofectamine
2000 (Invitrogen, Inc.) or FuGENE 6 (Roche Applied Sciences). Luciferase
assays were performed on a Turner Designs Luminometer, model TD-
20/20 using Dual Luciferase Reporter Assay System (Promega).
Human Cell Line Propagation and Endogenous Human SPL Expres-
sion—The HEK293 embryonic kidney cell line (ATCC, Manassas, VA)
was propagated in Dulbecco’s modified Eagle’s medium H-21 plus 10%
fetal bovine serum under standard conditions. The MDA-MB-435
breast cancer cell line (gift of Janet Price, MD Anderson Cancer Center,
Houston, TX) was propagated in RPMI plus 10% serum. For detection
of endogenous human SPL by immunoblotting, a peptide matching the
C terminus of the human SPL was synthesized and used to immunize
a rabbit for the production of polyclonal antibodies, as described previ-
ously (11). The antisera were pooled, and an equal volume of saturated
ammonium sulfate was added slowly while stirring on ice. The pH was
adjusted to 7.0 with 0.5 N HCl, and the solution was left with gentle
stirring overnight at 4 °C. After centrifugation at 3000  g for 30 min,
the pellet was dissolved in PBS, pH 7.0, and dialyzed against PBS, pH
7.0, overnight at 4 °C. After centrifugation at 10000  g for 10 min, the
supernatant was applied to an affinity column of 10 mg of peptide
antigen coupled to 1 g of CNBr-activated Sepharose 4B. Coupling was
carried out as recommended by the manufacturer (Sigma). Antibodies
were applied to this column by cycling overnight with a flow of 6 ml/h at
4 °C and eluted from the column with 100 mM glycine, pH 2.0. The pH
of the eluted antibody solution was immediately neutralized by adding
1 volume of 1 M Tris, pH 8.0, and dialyzed overnight against PBS, pH
7.0, containing 0.02% NaN3.
RESULTS
Deletion Analysis of the SPL Promoter—In previous studies,
we showed that a 512-nucleotide intergenic region between the
C. elegans SPL open reading frame and the upstream gene
T07A9.1 is sufficient to drive gut-restricted and developmen-
tally regulated expression of an SPL reporter (24). The reporter
expression pattern emulates the timing and spatial distribu-
tion of endogenous SPL expression, as determined by in situ
hybridization (48). To identify specific regions of this promoter
sequence implicated in the regulation of SPL gene expression,
deletion analysis was performed. Promoter fragments contain-
ing variable lengths of sequences upstream of the ATG start
site were generated from the full-length promoter by PCR
amplification and cloned into the pPD95.75 GFP reporter plas-
mid (Fig. 1). These reporter constructs were then used to gen-
erate transgenic animals by simultaneous microinjection of
FIG. 1. Deletion analysis of C. elegans SPL promoter. Promoter
fragments containing variable lengths of sequence upstream of the ATG
start site as designated above were generated from the full-length
512-nucleotide promoter by PCR and cloned into the pPD95.75 GFP
reporter plasmid. Site-directed mutagenesis of the conserved TGATAA
to CGATCC was performed as described under “Experimental Proce-
dures.” nt, nucleotides.
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reporters and dpy-20 plasmid pMH86 into dpy-20(e1362)
worms and subsequent identification of transformants by res-
cue of the Dpy phenotype, as described previously (24, 36). As
shown in Fig. 2, stable lines in which transcription of the GFP
reporter was under the control of a fragment containing 350
nucleotides of the sequences upstream of the ATG start site
demonstrated a pattern of expression indistinguishable from
that observed in transgenics expressing the full-length reporter
with regard to timing, tissue distribution, and intensity. Max-
imal expression occurred at larval stage L1 and later and was
maintained through adulthood. Expression was present
throughout the gut, with highest intensity notable in regions
just posterior to the pharynx (first intestinal ring) and just
anterior to the anus (ninth intestinal ring). In contrast, worms
containing transgenes harboring fragments with 275 or fewer
nucleotides upstream of the ATG start site did not yield detect-
able expression (Fig. 2). Constructs containing 300 nucleotides
upstream of the start site drove expression at 15% of normal
levels, thus defining a minimal promoter sequence. Promoters
containing 330 nucleotides upstream of the start site exhibited
an intermediate level of expression. These findings, which are
represented quantitatively in Table II, demonstrate that C.
elegans SPL transcription is controlled by a basal promoter
contained within the 300-nucleotide sequence upstream of the
ATG start site, with increasing intensity and distribution of
expression throughout the gut provided by sequences between
300 and 350 nucleotides from the ATG start site.
A GATA Element Is Required for Normal SPL Expression—
Inspection of the full-length 512-nucleotide intergenic sequence
between SPL and T07A9.1 revealed a GATA factor-binding
motif at 315 to 320 with respect to the start codon of the
lyase gene. Furthermore, the gut-restricted expression pattern,
developmental timing, and adult persistence of C. elegans SPL
expression were similar to that reported for the GATA tran-
scription factor ELT-2 (49). These observations suggested that
SPL gene expression might be regulated by a GATA transcrip-
tion factor. To determine whether the TGATAAmotif located at
315 to 320 is involved in regulating SPL gene expression in
vivo, site-directed mutagenesis was utilized to convert the mo-
tif to CGATCC in the 350-nucleotide construct. Transgenic
worms expressing this construct were then generated as de-
scribed under “Experimental Procedures” and examined for
GFP expression. As shown in Fig. 3, mutation of the TGATAA
motif led to a significant reduction in expression. The intensity
of the GFP signal in the 350-nucleotide mutant promoter con-
struct was reduced by 86% in the anterior gut and 25% in the
posterior (Table II). These results suggest that the GATA fac-
tor-binding motif is required for maximal gut-specific expres-
sion and that mutation, deletion, or loss of sequences immedi-
ately adjacent to this motif lead to reduced GATA factor
binding and expression.
Binding of ELT-2 to SPL GATA Elements—To establish the
role of ELT-2 in SPL gene expression, we next examined
whether the ELT-2 protein is capable of binding to the SPL
promoter GATA element. Toward that end, an ELT-2-GST
fusion protein was constructed, expressed in E. coli, and semi-
purified by glutathione affinity chromatography. ELT-2-GST
was shown to bind specifically to a 47-nucleotide DNA probe
containing the TGATAA motif in an electrophoretic mobility
shift assay, whereas GST alone was unable to bind the probe
(Fig. 4A). To determine the specificity of ELT-2 binding, com-
petition for binding was performed using an unlabeled oligomer
corresponding to sequences within the promoter of the C. el-
egans MT gene. C. elegans MT transcription is known to be
regulated by ELT-2 via a GATA motif present in the MT oli-
gomer (42). As demonstrated in Fig. 4A, both 10- and 100-fold
excess of an oligomer representing the wild type MT promoter
competes successfully with the SPL promoter probe for ELT-2
binding. However, mutation of the GATA-binding motif pre-
vents competition for ELT-2 binding even at 100-fold excess.
Similar experiments performed with purified ELT-2 protein
and competition using unlabeled oligomers corresponding to
sequences within the promoter of the SPL gene confirm that
successful competition for binding requires the presence of a
wild type GATA-binding motif (Fig. 4B). These findings dem-
onstrate that ELT-2 binds specifically to the GATA-binding
motif of the SPL promoter in vitro. In contrast to our results
with ELT-2, EMSA performed using ELT-7, a second putative
GATA factor expressed in the nematode gut,2 resulted in no
detectable binding to the SPL promoter (data not shown).
These findings demonstrate that the interaction between
ELT-2 and the SPL promoter is specific and that at least one
other gut-specific nematode GATA factor is unable to substi-
tute for ELT-2 in this interaction.
ELT-2 Is Required for SPL-driven Reporter Expression—We
sought to determine whether interactions between the ELT-2
transcription factor and GATA elements in the SPL promoter
are required for normal SPL expression in C. elegans. Toward
that end, RNAi was used to knock down expression of ELT-2 in
worms expressing the 350-nucleotide SPL-driven reporter. In-
hibition of ELT-2 expression produces a distinctive gut-ob-
structed phenotype, characterized by lack of patency of the gut
lumen (49). In the absence of ELT-2 expression, animals arrest
at the L1 larval stage and die within several days due to
starvation. In order to rule out the possibility that inhibition of
SPL reporter expression observed in the ELT-2 RNAi-treated
worms might result from a general effect of L1 larval arrest,
control experiments were simultaneously performed in SPL
reporter worms using RNAi against acn-1, which results in L1
arrest due to a hypodermal defect (50). As shown in Fig. 5, L1
arrested progeny of acn-1 RNAi-treated worms demonstrated
strong reporter expression throughout the gut, similar to the
2 J. Rothman and K. Strohmaier, personal communication.
FIG. 2. Expression pattern of SPL GFP reporters. Transforma-
tion of worms was performed by microinjection with plasmid DNA as
described under “Experimental Procedures.” Several stable lines were
generated for each construct and visualized by mounting live transgenic
nematodes on 5% agarose and viewing by Nomarski optics and by
fluorescence microscopy with a Chroma High Q GFP long pass filter.
Transgenic worms containing constructs of 200, 250, and 275 nucleo-
tides upstream of the start codon demonstrated background fluores-
cence similar to the 129-nucleotide construct and are not shown. In each
case 20 worms were analyzed.
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pattern observed in the 350-nucleotide reporter worms shown
in Fig. 2. In marked contrast, worms treated with elt-2 RNAi
demonstrated little or no SPL reporter expression. These find-
ings suggest that ELT-2 is necessary for SPL expression in the
developing intestine.
In Vivo Activation of SPL Transcription by ELT-2 Expressed
in Yeast—To assess the ability of ELT-2 to drive SPL expres-
sion in vivo, we took advantage of the fact that ELT-2, when
expressed in a heterologous yeast system, is still capable of
activating transcription of its target reporter genes (28, 44).
Yeast cells were co-transfected with a construct containing
elt-2 under regulation of a galactose-inducible promoter along
with lacZ reporters under the control of the SPL GATA ele-
ments (Fig. 6A). As shown in Fig. 6B, GATA motifs from the
SPL promoter in either forward or reverse orientations pro-
moted reporter expression in vivo in response to the ELT-2
presence, as demonstrated by significant -galactosidase activ-
ity upon ELT-2 induction. In contrast, a construct containing
ELT-2 in the antisense orientation did not promote reporter
expression regardless of the orientation of GATA motifs. In
addition, ELT-7 did not lead to activation of SPL in this system
(Fig. 6C).
GATA Factors Induce Expression of Human SPL in Vivo—
The ELT-2 protein sequence is homologous to GATA-4/5/6 tran-
scription factors, which are important regulators of mamma-
lian development and gene expression in heart, liver, gonad,
gut epithelium, and lung. Analysis of the human SPL promoter
using the MATInspector software (www.genomatix.de) re-
vealed several GATA sites at 2550, 2014, 1760 and 170
nucleotides with respect to the ATG start codon. To address
whether human SPL gene expression is regulated by GATA
factors, the human SPL promoter was cloned; luciferase re-
TABLE II
Quantitative analysis of reporter fluorescence intensity
Reporter Fluorescence No.pixels No. Fluorescence/pixel % 350 vs. 350 vs. GATA vs. N2
Anterior gut (int1DL/VL or DR/VR)
350 2515.35 50,000 0.0503 100.00
350 GATA 348.68 50,000 0.0070 13.86 p  0.0001a
330 1436.87 50,000 0.0287 57.12 p  0.0001a p  0.0001a
300 409.25 50,000 0.0082 16.27 p  0.0001a
275 48.05 50,000 0.0010 1.91 p  0.0001a p  0.05 NSb
N2 0 50,000 0.0000 0.00
Posterior gut (int9L/R)
350 1507.17 40,000 0.0377 100.00
350 GATA 1125.59 40,000 0.0281 74.68 p  0.05 NSb
330 486 40,000 0.0122 32.25 p  0.0001a p  0.005c
300 185.36 40,000 0.0046 12.30 p  0.0001a
275 9.15 40,000 0.0002 0.61 p  0.0001a p  0.05c
N2 0 40,000 0.0000 0.00
a Values indicate extremely significant.
b NS indicates not significant.
c Values indicate highly significant.
d Values indicate significant.
FIG. 3. Mutation of the GATA factor-binding site leads to di-
minished SPL expression. Transgenic worms containing a GFP re-
porter under regulation of a 350-nucleotide SPL promoter in which the
GATA factor-binding motif TGATAA has been changed to CGATCC
were generated and visualized by Nomarski optics and fluorescence
microscopy. Worms in which this GATA motif has been mutated dem-
onstrate a marked reduction in reporter expression compared with
those containing the wild type sequence.
FIG. 4. ELT-2 interacts with the SPL promoter in vitro. A ra-
diolabeled probe corresponding to a DNA sequence in the SPL promoter
containing the conserved GATA factor-binding motif (Table I) was in-
cubated with semi-purified ELT-2-GST (A), as described under “Exper-
imental Procedures.” Competition for binding was performed using
10- or 100-fold concentration of oligonucleotides corresponding to a
sequence of the wild type C. elegans MT promoter (MT WT) shown
previously to bind ELT-2 or a mutant MT promoter sequence lacking
the TGATAA motif (MT Mutant). purified ELT-2 protein was used,
rather than the ELT-2-GST fusion, and competition for binding was
performed using 10- or 100-fold concentration of oligonucleotides cor-
responding to a sequence of the wild type SPL promoter (SPL WT) or a
mutant SPL promoter sequence lacking the TGATAA motif (SPL Mu-
tant) (B).
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porter constructs were generated, and the effect of GATA factor
expression on reporter induction was evaluated. As shown in
Fig. 7, A and B, SPL reporter constructs were strongly induced
by GATA-4 expression in HEK293 cells and in MDA-MB-435
breast cancer cells. GATA-4 transfection also led to increased
expression of endogenous SPL, as determined by immunoblot-
ting with a polyclonal antibody specific for mammalian SPL
(Fig. 8) and an increase in SPL enzymatic activity (data
not shown).
DISCUSSION
S1P has emerged as an important signaling molecule that
regulates mammalian cell fate decisions, motility, differentia-
tion, and angiogenesis (51). Although S1P induces signals
through both extracellular and intracellular mechanisms, the
putative role of S1P as a second messenger remains controver-
sial, mainly due to the lack of identified downstream intracel-
lular targets. The genomes of Saccharomyces cerevisiae, D.
melanogaster, and C. elegans contain genes involved in S1P
and long chain base metabolism (52). However, extracellular
S1P receptors of the Edg family have not been found in simple
metazoans and do not appear to have evolved prior to chor-
dates. Thus, these non-mammalian models may present ideal
systems in which to elucidate receptor-independent S1P func-
tions, mechanisms of action, and metabolism.
Toward that end, we have explored the role of the S1P-
catabolizing enzyme SPL in the developmental programs of two
genetically tractable metazoan models. We found that the SPL
genes of both C. elegans and Drosophila are developmentally
FIG. 5. ELT-2 is required for SPL expression in vivo. Adult
hermaphrodites expressing transgenic arrays of a 350-nucleotide SPL
promoter-driven reporter were injected with dsRNA corresponding to
elt-2 (lower panel) or acn-1 (upper panel). The F1 progeny of worms
injected with elt-2 RNAi were evaluated for L1 arrest and “gut-ar-
rested” phenotype, indicating loss of ELT-2 function. Worms demon-
strating a phenotype consistent with ELT-2 loss of function exhibit
minimal fluorescent SPL reporter expression, as shown in lower panel.
In contrast, the L1-arrested F1 progeny of worms injected with acn-1
RNAi strongly express the fluorescent SPL reporter in a pattern similar
to the untreated reporter worms shown in Figs. 2 and 3. Scale bar
represents 100 m.
FIG. 6. ELT-2 induces expression of SPL in vivo. In the heterol-
ogous yeast expression system, C. elegans GATA transcription factors
are expressed under regulation of a galactose-inducible promoter and
evaluated for their ability to activate expression of a -galactosidase
reporter driven by a C. elegans target gene promoter (A). ONP, o-
nitrophenyl;ONPG, o-nitrophenyl -D-galactopyranoside. Expression of
ELT-2 from a construct in which it is in the sense orientation ()
activates an SPL -galactosidase (-GAL) reporter with a GATA motif
in either forward or reverse orientations in yeast (B). In contrast,
expression of ELT-7 does not activate an SPL reporter (C). The pro-
moter of the ges-1 gene contains GATA elements known to be respon-
sive to ELT-2 and was used as a positive control for reporter expression.
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regulated, demonstrate gut-restricted expression, and are es-
sential for normal development, viability, and reproduction (23,
24). In C. elegans, a relatively small DNA sequence upstream of
the SPL open reading frame appears sufficient to drive expres-
sion of a reporter gene in a temporally and spatially regulated
manner that is consistent with the expression pattern of the
endogenous gene. Therefore, we chose this system to explore
mechanisms of SPL gene regulation. The similarity between
the expression patterns ofDrosophila and C. elegans SPL genes
suggests that mechanisms of gene regulation identified in C.
elegans might be relevant to the regulation of SPL genes of
other species especially, but not necessarily, limited to the
ecdysozoa (animals with a cuticle that is molted) (53). Further-
more, our results as well as recent work from the laboratory of
Ruth Lehmann indicate that the temporal and tissue-specific
expression patterns of additional Drosophila genes affecting
long chain base metabolism, including sphingosine kinase, ce-
ramidase, and ceramide kinase, are similar to that of SPL (54,
55). These observations suggest the potential for coordinated
regulation of these genes in metazoans.
In the current study, we investigated the mechanisms of SPL
gene regulation in C. elegans. Deletion analysis of the C. el-
egans SPL promoter defined a 350-nucleotide sequence suffi-
cient to drive maximal and temporally and spatially regulated
expression of a GFP reporter. Analysis of additional deletion
constructs identified different regions within this sequence
necessary for both basal and enhanced expression, suggesting
that multiple DNA cis-elements and their cognate binding fac-
tors orchestrate SPL expression within the context of the de-
veloping nematode gut. Abolition of the GATA factor binding
site at 315 to 320 in this promoter led to markedly dimin-
ished expression, while the developmental timing of expression
was maintained. These findings suggest that a GATA tran-
scription factor regulates the level of SPL expression through
interactions with the DNA at this site, and that other regula-
tory elements may contribute to the pattern and timing of
expression. Although reporter expression was largely ablated
in the anterior gut cells of the GATA mutated reporter, some
expression remained in the posterior gut cells. This may rep-
resent a nonspecific signal, since this anatomical region has
been reported to be a frequent site of nonspecific expression,
possibly due to weak promoter and/or enhancer signals con-
tained within the vectors (56). Alternatively, other cis-elements
within the SPL promoter may contribute to expression in the
posterior gut.
DNA binding assays along with corresponding competition
assays using wild type and mutant ELT-2-binding sequences
from both the SPL and the MT promoter (a known target of
ELT-2) demonstrate direct and specific binding of ELT-2 to
sequences in the SPL promoter in vitro. Inhibition of ELT-2
expression using RNAi led to loss of GFP expression in trans-
genic reporter worms, demonstrating that SPL expression is
regulated by ELT-2 in the developing gut. In addition to dem-
onstrating that ELT-2 is required for C. elegans SPL expres-
sion, the heterologous yeast expression system established that
ELT-2 is capable of inducing SPL expression in vivo.
Most interestingly, a second GATA factor-binding motif exists
in reverse orientation in the SPL promoter at 291 to 296, in
close proximity to the motif we have analyzed. This motif con-
tains the sequence ACTGATAA, which is found in several C.
elegans gut-specific genes including the acid phosphatase pho-1,
recently identified as a target of ELT-2 transcriptional regulation
(39). This 8-nucleotide motif may be important for coordinated
regulation of gene expression during intestinal development in
nematodes. Furthermore, SPL cDNAs containing both SL1 and
SL2 leader sequences have been identified in the C. elegans
genomic data base Wormbase WS130 (www.wormbase.org), in-
dicating that SPL, in addition to being driven by its own proximal
promoter, may be a member of an operon. Future studies should
clarify whether these factors play a significant role in the regu-
lation of SPL expression.
Formation of the digestive system during C. elegans embry-
ogenesis is regulated by a developmental program involving a
cascading network of endoderm-specific transcription factors
required for gut formation and the maintenance of gut integrity
(27). Among these, a series of GATA transcription factors is
FIG. 7. Human SPL gene expression is induced by GATA fac-
tors. Cells were co-transfected with human SPL reporters and con-
structs driving constitutive expression of GATA-4. Luciferase activity
was measured as described under “Experimental Procedures.” Results
with pLG3-KpnI constructs are shown. Similar results were obtained
with pLG3-BamHI constructs. A, MDA-MB-435 breast cancer cells; B,
HEK293 cells.
FIG. 8. Endogenous expression of human SPL is induced by
GATA factors. HEK293 cells were transiently transfected with either
pcDNA3.0 vector control or GATA-4 cDNA as described under “Exper-
imental Procedures.” Whole cell extracts were obtained at 48 h after
transfection, and immunoblotting was performed with polyclonal anti-
body specific for mammalian SPL. Immunoblotting with an actin-spe-
cific antibody was performed as loading control. The results from two
separate transfection experiments are depicted in this figure.
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sequentially expressed within the developing endoderm begin-
ning with the END-1 protein (29, 57) (expressed in E founder
cells that give rise to all endodermal tissue) and including the
GATA transcription factor, ELT-2, identified through its ability
to bind two canonical GATA sites that regulate expression of
the gut-specific esterase (ges-1) gene (30). ELT-2 expression is
restricted to intestinal cells in embryonic and post-embryonic
developmental stages, in a pattern similar to that observed for
C. elegans SPL. END-1, END-3, ELT-2, and ELT-4 are GATA
transcription factors expressed in the developing gut. Whereas
END-1 and END-3 are expressed early and are involved in
initiating the entire program of endodermal development,
ELT-2 expression occurs later and is required for intestinal
differentiation but not endodermal specification. The DNA
binding domain of ELT-2 is homologous to the corresponding
domains of gut-associated GATA transcription factors includ-
ing vertebrate GATA-4, -5, and -6 and Drosophila serpent (58).
C. elegans GATA-4 is a very small protein of 74 residues that
may play a minor role in gut development (28).
We showed recently that overexpression of SPL in human
cells potentiates stress-induced apoptosis through its influence
on the intracellular levels of S1P and ceramide, two biochem-
ically related bioactive sphingolipid metabolites with generally
opposing effects on cell fate and survival (11). The ability of
SPL to lower S1P levels and simultaneously elevate ceramide
levels suggests that this enzyme may provide a novel target for
diseases such as cancer in which these biomodulators are dys-
regulated and cell fate decisions are pathologically affected. By
elucidating the mechanisms that regulate expression of SPL
and other genes of S1P metabolism, it may become feasible to
manipulate expression of these genes, their protein products,
and subsequently intracellular S1P and ceramide levels in
order to influence cell fate in vivo for therapeutic purposes. It is
interesting to note that GATA-4, -5, and -6 have been impli-
cated in the regulation of apoptosis and may contribute to
tumorigenesis (47, 59–62). Thus, our findings may provide
insight regarding the potential role of SPL in the regulation of
cell fate, stress responses, and carcinogenesis.
In summary, the current study demonstrates that GATA
transcription factors regulate SPL expression in nematodes
and humans. Our findings thus appear to represent a con-
served regulatory mechanism operational in the control of SPL
expression. Further study of SPL gene regulation in C. elegans
and other organisms is warranted and may potentially provide
insight into how S1P metabolism adjusts and responds to
changing cellular conditions and is coordinated with the com-
plex signaling programs involved in animal development.
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